CLINICAL SIGNIFICANCE OF THE TP53 MUTATION STATUS IN DIFFUSE LARGE B-CELL LYMPHOMA

Objective: to reveal the clinical significance of the mutation status of the TP53 gene in the group of receiving rituximab therapy patients with diffuse large B-cell lymphoma (DLBCL) in Novosibirsk. Material and methods. A total of 74 patients with DLBCL, who have been hospitalized at the City Hemat...

ver descrição completa

Detalhes bibliográficos

Principais autores:	E. N. Voropaeva, T. I. Pospelova, M. I. Voevoda, V. N. Maksimov
Formato:	Artigo
Idioma:	Russo
Publicado em:	Russian Academy of Sciences, Siberian Branch Publishing House 2019-03-01
coleção:	Сибирский научный медицинский журнал
Assuntos:	gene tp53 mutations diffuse large b-cell lymphoma rituximab prognosis target therapy
Acesso em linha:	https://sibmed.elpub.ru/jour/article/view/105
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!